Commonwealth Equity Services’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
59,409
-4,327
| -7% | -$115K | ﹤0.01% | 2188 |
|
|
2025
Q1 | $1.54M | Sell |
63,736
-7,457
| -10% | -$180K | ﹤0.01% | 2116 |
|
|
2024
Q4 | $2.87M | Buy |
71,193
+15,244
| +27% | +$613K | ﹤0.01% | 1617 |
|
|
2024
Q3 | $3.54M | Buy |
55,949
+14,277
| +34% | +$904K | 0.01% | 1462 |
|
|
2024
Q2 | $2.21M | Buy |
41,672
+24,332
| +140% | +$1.29M | ﹤0.01% | 1722 |
|
|
2024
Q1 | $1.42M | Buy |
+17,340
| New | +$1.42M | ﹤0.01% | 2004 |
|
|
2020
Q2 | – | Sell |
-10,001
| Closed | -$46K | – | 3014 |
|
|
2020
Q1 | $46K | Buy |
+10,001
| New | +$46K | ﹤0.01% | 2695 |
|
|
2019
Q3 | – | Sell |
-16,500
| Closed | -$136K | – | 2886 |
|
|
2019
Q2 | $136K | Hold |
16,500
| – | – | ﹤0.01% | 2594 |
|
|
2019
Q1 | $164K | Hold |
16,500
| – | – | ﹤0.01% | 2516 |
|
|
2018
Q4 | $126K | Sell |
16,500
-1,500
| -8% | -$11.5K | ﹤0.01% | 2447 |
|
|
2018
Q3 | $313K | Buy |
+18,000
| New | +$313K | ﹤0.01% | 2143 |
|